Nobilis Multriva Gm+REOm (--) + (--) + (--) + (--) - Emulsion for injection
Nobilis Multriva Gm+REOm (--) + (--) + (--) + (--) - Emulsion for injection
Authorised
- Infectious bursal disease virus, strain GB02, Inactivated
- Infectious bursal disease virus, strain 89/03, Inactivated
- Avian reovirus, strain ARV-1, Inactivated
- Avian reovirus, strain ARV-4, Inactivated
Product identification
Medicine name:
Nobilis Multriva Gm+REOm (--) + (--) + (--) + (--) - Emulsion for injection
Active substance:
- Infectious bursal disease virus, strain GB02, Inactivated
- Infectious bursal disease virus, strain 89/03, Inactivated
- Avian reovirus, strain ARV-1, Inactivated
- Avian reovirus, strain ARV-4, Inactivated
Target species:
-
Chicken
Route of administration:
-
Intramuscular use
Product details
Active substance and strength:
-
Infectious bursal disease virus, strain GB02, InactivatedPresentation_strength:≥ 100.9 U Reference:EMEA/V/VAMF/0005 Index:0
-
Infectious bursal disease virus, strain 89/03, InactivatedPresentation_strength:≥ 88.6 U Reference:EMEA/V/VAMF/0006 Index:1
-
Avian reovirus, strain ARV-1, InactivatedPresentation_strength:≥ 11.5 U Reference:EMEA/V/VAMF/0007 Index:2
-
Avian reovirus, strain ARV-4, InactivatedPresentation_strength:≥ 11.4 U Reference:EMEA/V/VAMF/0008 Index:3
Pharmaceutical form:
-
Emulsion for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Chicken
-
Not applicable0dayZero days
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI01AA22
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Austria
-
Belgium
-
Bulgaria
-
Croatia
-
Cyprus
-
Czechia
-
Denmark
-
Estonia
-
Finland
-
France
-
Germany
-
Greece
-
Hungary
-
Iceland
-
Ireland
-
Italy
-
Latvia
-
Liechtenstein
-
Lithuania
-
Luxembourg
-
Malta
-
Netherlands
-
Norway
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
Package description:
- Packaging:Bottle (PET), Package_size:1 bottle, Content:300 ml (1000 doses)
- Packaging:Bottle (PET), Package_size:1 bottle, Content:600 ml (2000 doses)
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - known active substance (Article 8 of Regulation (EU) 2019/6)
Marketing authorisation holder:
- Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Intervet International B.V.
Responsible authority:
- European Commission
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
English (PDF)
Download Published on: 9/06/2025
Bulgarian (PDF)
Published on: 9/06/2025
Croatian (PDF)
Published on: 9/06/2025
Czech (PDF)
Published on: 9/06/2025
Danish (PDF)
Published on: 9/06/2025
Dutch (PDF)
Published on: 9/06/2025
Estonian (PDF)
Published on: 9/06/2025
Finnish (PDF)
Published on: 9/06/2025
French (PDF)
Published on: 9/06/2025
German (PDF)
Published on: 9/06/2025
Greek (PDF)
Published on: 9/06/2025
Hungarian (PDF)
Published on: 9/06/2025
Icelandic (PDF)
Published on: 9/06/2025
Italian (PDF)
Published on: 9/06/2025
Latvian (PDF)
Published on: 9/06/2025
Lithuanian (PDF)
Published on: 9/06/2025
Maltese (PDF)
Published on: 9/06/2025
Norwegian (PDF)
Published on: 9/06/2025
Polish (PDF)
Published on: 9/06/2025
Portuguese (PDF)
Published on: 9/06/2025
Romanian (PDF)
Published on: 9/06/2025
Slovak (PDF)
Published on: 9/06/2025
Slovenian (PDF)
Published on: 9/06/2025
Spanish (PDF)
Published on: 9/06/2025
Swedish (PDF)
Published on: 9/06/2025
ema-puar-v6614-nobilismultrivagmreom-initial-en.pdf
English (PDF)
Download Published on: 12/09/2025